These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21840596)

  • 1. Cooperation between somatic Ikaros and Notch1 mutations at the inception of T-ALL.
    Sontani Y; Chapman G; Papathanasiou P; Dunwoodie S; Goodnow CC; Hoyne GF
    Leuk Res; 2011 Nov; 35(11):1512-9. PubMed ID: 21840596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ikaros regulates Notch target gene expression in developing thymocytes.
    Chari S; Winandy S
    J Immunol; 2008 Nov; 181(9):6265-74. PubMed ID: 18941217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ikaros is a critical target during simultaneous exposure to X-rays and N-ethyl-N-nitrosourea in mouse T-cell lymphomagenesis.
    Hirano S; Kakinuma S; Amasaki Y; Nishimura M; Imaoka T; Fujimoto S; Hino O; Shimada Y
    Int J Cancer; 2013 Jan; 132(2):259-68. PubMed ID: 22684892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL.
    Jeannet R; Mastio J; Macias-Garcia A; Oravecz A; Ashworth T; Geimer Le Lay AS; Jost B; Le Gras S; Ghysdael J; Gridley T; Honjo T; Radtke F; Aster JC; Chan S; Kastner P
    Blood; 2010 Dec; 116(25):5443-54. PubMed ID: 20829372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
    Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
    PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Larson Gedman A; Chen Q; Kugel Desmoulin S; Ge Y; LaFiura K; Haska CL; Cherian C; Devidas M; Linda SB; Taub JW; Matherly LH
    Leukemia; 2009 Aug; 23(8):1417-25. PubMed ID: 19340001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
    Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
    Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.
    Ashworth TD; Pear WS; Chiang MY; Blacklow SC; Mastio J; Xu L; Kelliher M; Kastner P; Chan S; Aster JC
    Blood; 2010 Dec; 116(25):5455-64. PubMed ID: 20852131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice.
    Dumortier A; Jeannet R; Kirstetter P; Kleinmann E; Sellars M; dos Santos NR; Thibault C; Barths J; Ghysdael J; Punt JA; Kastner P; Chan S
    Mol Cell Biol; 2006 Jan; 26(1):209-20. PubMed ID: 16354692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia.
    Witkowski MT; Cimmino L; Hu Y; Trimarchi T; Tagoh H; McKenzie MD; Best SA; Tuohey L; Willson TA; Nutt SL; Busslinger M; Aifantis I; Smyth GK; Dickins RA
    Leukemia; 2015 Jun; 29(6):1301-11. PubMed ID: 25655195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-ALL treated according to the NOPHO ALL-1992 and ALL-2000 protocols.
    Fogelstrand L; Staffas A; Wasslavik C; Sjögren H; Söderhäll S; Frost BM; Forestier E; Degerman S; Behrendtz M; Heldrup J; Karrman K; Johansson B; Heyman M; Abrahamsson J; Palmqvist L
    Pediatr Blood Cancer; 2014 Mar; 61(3):424-30. PubMed ID: 24424791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of HES1 transcriptional programs in T-ALL.
    Schnell SA; Ambesi-Impiombato A; Sanchez-Martin M; Belver L; Xu L; Qin Y; Kageyama R; Ferrando AA
    Blood; 2015 Apr; 125(18):2806-14. PubMed ID: 25784680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression.
    Cialfi S; Palermo R; Manca S; Checquolo S; Bellavia D; Pelullo M; Quaranta R; Dominici C; Gulino A; Screpanti I; Talora C
    Leukemia; 2013 Feb; 27(2):485-8. PubMed ID: 22846929
    [No Abstract]   [Full Text] [Related]  

  • 14. Ikaros represses the transcriptional response to Notch signaling in T-cell development.
    Kleinmann E; Geimer Le Lay AS; Sellars M; Kastner P; Chan S
    Mol Cell Biol; 2008 Dec; 28(24):7465-75. PubMed ID: 18852286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ikaros directly represses the notch target gene Hes1 in a leukemia T cell line: implications for CD4 regulation.
    Kathrein KL; Chari S; Winandy S
    J Biol Chem; 2008 Apr; 283(16):10476-84. PubMed ID: 18287091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating Notch1 mutations are an early event in T-cell malignancy of Ikaros point mutant Plastic/+ mice.
    Mantha S; Ward M; McCafferty J; Herron A; Palomero T; Ferrando A; Bank A; Richardson C
    Leuk Res; 2007 Mar; 31(3):321-7. PubMed ID: 16870249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis.
    Gómez-del Arco P; Kashiwagi M; Jackson AF; Naito T; Zhang J; Liu F; Kee B; Vooijs M; Radtke F; Redondo JM; Georgopoulos K
    Immunity; 2010 Nov; 33(5):685-98. PubMed ID: 21093322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hes1 mediates the different responses of hematopoietic stem and progenitor cells to T cell leukemic environment.
    Tian C; Zheng G; Cao Z; Li Q; Ju Z; Wang J; Yuan W; Cheng T
    Cell Cycle; 2013 Jan; 12(2):322-31. PubMed ID: 23255132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
    Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
    Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes.
    Tremblay M; Tremblay CS; Herblot S; Aplan PD; Hébert J; Perreault C; Hoang T
    Genes Dev; 2010 Jun; 24(11):1093-105. PubMed ID: 20516195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.